NCT00267150View on ClinicalTrials.gov

Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Simultaneous Pancreas-Kidney Transplants

PHASE3CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Pancreas TransplantationKidney Transplantation
Interventions
DRUG

Enteric-coated mycophenolate sodium (EC-MPS)

Experimental

Trial Locations (1)

13353

Universitätsklinikum Charité Campus Virchow Klinikum Berlin Nephrologie und Internistische Intensivmedizin, Berlin

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY